Other News

iBeat, the Lifesaving Smartwatch, Extends Seed Round to $4.5 Million; Builds Out Executive Bench with Hires from Apple and Stanford

SAN FRANCISCO–(BUSINESS WIRE)–iBeat, a wearable technology company empowering people to live longer lives, today announced it has closed another $3 million in funding, bringing its total seed stage funding to $4.5 million. New investors include WTI, SV Tech Ventures, Lee Equity, and renowned entrepreneurs and angel investors Michael Rubin, Mark Burg, and Harald Ludwig. They join […]

Robbins Arroyo LLP: Avinger, Inc. (AVGR) Misled Shareholders According to a Class Action

SAN DIEGO & REDWOOD CITY, Calif.–(BUSINESS WIRE)–Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Avinger, Inc. (NasdaqGM: AVGR) on behalf of all purchasers of Avinger securities pursuant to the company’s initial public offering on January 30, 2015 (the “Offering”), for alleged violations of the […]

Gore Announces First-in-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR

FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) today announced the first patient implant of the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System after receiving CE Mark last month. The first implant was performed by Prof. Dr. med. Giovanni Torsello and Dr. med. Martin Austermann at […]

Clinical Trial to Evaluate Medtronic Cryoablation as First-Line Treatment for Patients With Symptomatic Paroxysmal Atrial Fibrillation

Press Release DUBLIN – July 11, 2017 – Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the safety and effectiveness of performing pulmonary vein isolation (PVI) with the Arctic Front Advance(TM) Cryoballoon in patients with symptomatic paroxysmal atrial fibrillation (AF) prior […]

Medtronic Expands TAVR Access to More Patients With Symptomatic, Severe Aortic Stenosis Upon Intermediate Risk FDA Approval

Press Release DUBLIN – July 10, 2017 – Medtronic plc (NYSE: MDT) today announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM) transcatheter aortic valve replacement (TAVR) platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery. […]

Edwards Lifesciences To Host Earnings Conference Call On July 26, 2017

IRVINE, Calif., July 12, 2017 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, plans to announce its operating results for the quarter ended June 30, 2017 after the market closes on Wednesday, July 26, 2017, and will host a conference call at 5:00 […]

Andrew ElBardissi, M.D. Named to NeoChord Board of Directors

ST. LOUIS PARK, Minn., July 10, 2017 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative mitral regurgitation (DMR), today announced the appointment of Andrew ElBardissi, M.D. to its Board of Directors, effective immediately. Dr. ElBardissi is replacing Avi Kometz, […]